Magnetized wire could be used to detect cancer in people, scientists report

July 16, 2018, Stanford University Medical Center
Credit: CC0 Public Domain

A magnetic wire used to snag scarce and hard-to-capture tumor cells could prove to be a swift and effective tactic for early cancer detection, according to a study by researchers at the Stanford University School of Medicine.

The wire, which is threaded into a vein, attracts special magnetic nanoparticles engineered to glom onto that may be roaming the bloodstream if you have a tumor somewhere in your body. With these tumor cells essentially magnetized, the wire can lure the cells out of the free-flowing bloodstream using the same force that holds family photos to your refrigerator.

The technique, which has only been used in pigs so far, attracts from 10-80 times more tumor cells than current -based cancer-detection methods, making it a potent tool to catch the disease earlier. The technique could even help doctors evaluate a patient's response to particular cancer treatments: If the therapy is working, tumor-cell levels in the blood should rise as the cells die and break away from the tumor, and then fall as the tumor shrinks.

For now, Sam Gambhir, MD, Ph.D., professor and chair of radiology and director of the Canary Center at Stanford for Cancer Early Detection, is focused on the wire as a cancer-detection method, but its reach could be much broader.

"It could be useful in any other disease in which there are cells or molecules of interest in the blood," said Gambhir, who developed the wire with the help of his colleagues. "For example, let's say you're checking for a bacterial infection, circulating tumor DNA or rare cells that are responsible for inflammation in any of these scenarios, the wire and nanoparticles help to enrich the signal, and therefore detect the disease or infection."

The study will be published online July 16 in Nature Biomedical Engineering. Gambhir is the senior author. Postdoctoral scholar Ophir Vermesh, MD, Ph.D.; surgery resident Tianjia Jessie Ge, MD; and MD-Ph.D. student Amin Aalipour share lead authorship.

No vial of blood necessary

Cells that have sloughed off the tumor and cruise the bloodstream freely, otherwise known as circulating tumor cells, can serve as cancer biomarkers, signaling the presence of the disease.

Why then, you might wonder, would you need an entirely new way to capture cells milling about the blood? Couldn't a simple blood draw siphon off the same floating tumor cells? Hypothetically, yes, but circulating tumor cells are often scarce, and a blood draw only samples a few milliliters of the total blood volume, which in adult humans is about 5 liters.

"These circulating tumor cells are so few that if you just take a regular blood sample, those test tubes likely won't even have a single circulating tumor cell in them," said Gambhir, the Virginia and D.K. Ludwig Professor of Clinical Investigation in Cancer Research. It would be like searching for a grain of sand in a bathtub, but only scooping out a few cups of water.

"So doctors end up saying, 'Okay, nothing's there.'"

That, Gambhir said, is where he sees the magnetic wire making a difference. For the wire, which is about the length of your pinky finger and the thickness of a paperclip, to work, circulating tumor cells must be effectively magnetized with nanoparticles. The nanoparticles contain an antibody that latches onto circulating tumor cells. Once the floating tumor cell and nanoparticle are hitched, the cell lugs the tiny magnet around with it, and when the cell-magnet complex flows past the wire, it's compelled by magnetic force to veer from its regular path in the bloodstream and stick to the wire. Then, the wire is removed from the vein, and the cells are stripped for analysis.

Gambhir and his team have yet to try out the wire in people, as they still have to file for approval from the Food and Drug Administration, but they have successfully tested it in pigs, placing the device in a vein near the pig's ear. That vein is fairly similar to veins in the human arm. When compared with a 5-millileter blood sample, the magnetic wire extracted 10-80 times more ; compared with a different, commercially available wire-based detection method, the wire picked up 500 to 5,000 more tumor cells.

"We estimate that it would take about 80 tubes of blood to match what the wire is able to sample in 20 minutes," Gambhir said. Of course, he continued, it's not practical to remove 80 test tubes of blood from one person; that's more than a half-liter. "So, we're hoping this approach will enrich our detection capability and give us better insight into just how rare these circulating are, and how early on they exist once the cancer is present."

A flexible wire

Gambhir said the technique could also be used to gather genetic information about tumors located in hard-to-biopsy places or to provide information about the efficacy of a cancer treatments. Perhaps most intriguingly, the magnetic wire may even stand to evolve into a treatment in and of itself.

"If we can get this thing to be really good at sucking up , you might consider an application where you leave the wire in longer term," Gambhir said. "That way it almost acts like a filter that grabs the cancer cells and prevents them from spreading to other parts of the body."

Now, Gambhir is working to ready the technique for humans, which involves approval for the nanoparticles. His lab is conducting toxicity studies in mice, paying close attention to what happens to leftover nanoparticles that don't bind. So far, there are no signs of toxicity, and the extras decay over the course of a few weeks, he said. Gambhir is also looking into nanoparticles that are already FDA-approved, working to tweak them for use with the . Once the technology is approved for humans, the goal is to develop it into a multi-pronged tool that will boost detection, diagnosis, treatment and evaluation of cancer therapy.

The work is an example of Stanford Medicine's focus on precision health, the goal of which is to anticipate and prevent disease in the healthy and precisely diagnose and treat disease in the ill.

Explore further: PET scan tracer predicts success of cancer 'vaccine,' study reports

More information: An intravascular magnetic wire for the high-throughput retrieval of circulating tumour cells in vivo, Nature Biomedical Engineering (2018). DOI: 10.1038/s41551-018-0257-3, https://www.nature.com/articles/s41551-018-0257-3

Related Stories

PET scan tracer predicts success of cancer 'vaccine,' study reports

May 14, 2018
By engineering a special molecule to track certain immune cells in the body, scientists at the Stanford University School of Medicine have invented a litmus test for the effectiveness of a newly devised cancer therapy.

Technique reveals movements of immune cells as they hunt for tumors

January 18, 2017
A study led by researchers at the Stanford University School of Medicine has for the first time demonstrated a way to visualize and monitor the behavior of immune cells used to treat cancer patients.

Blood test could provide cheaper, better way for doctors to manage lung cancer

December 12, 2016
Profiling the genes of lung-tumor cells from patient blood samples may be a cheap, noninvasive way to help doctors choose the right treatments, according to a study led by researchers at the Stanford University School of ...

Imaging agent helps predict success of lung cancer therapy

March 7, 2018
Doctors contemplating the best therapy for lung cancer patients may soon be able to predict the efficacy of a widely used lung cancer drug based on an imaging agent and a simple scan, according to the findings of a new clinical ...

Recommended for you

First immunotherapy success for triple-negative breast cancer

October 21, 2018
There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer.

Healthy diets linked to better outcomes in colorectal cancer

October 20, 2018
Colorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved their diets after being diagnosed, according to a new American Cancer Society ...

Why some cancers affect only young women

October 19, 2018
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...

Scientists to improve cancer treatment effectiveness

October 19, 2018
Together with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the National Research Nuclear University MEPhI have recently developed a quantum dot-based microarray ...

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.